Crossmark

Proteome-wide analysis of protein lipidation using chemical probes: in-gel fluorescence visualization, identification and quantification of N-myristoylation, N- and S-acylation, O-cholesterylation, S-farnesylation and S-geranylgeranylation

Crossref DOI link: https://doi.org/10.1038/s41596-021-00601-6

Published Online: 2021-10-27

Published Print: 2021-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Kallemeijn, Wouter W.

Lanyon-Hogg, Thomas https://orcid.org/0000-0002-7092-8096
Panyain, Nattawadee

Goya Grocin, Andrea

Ciepla, Paulina https://orcid.org/0000-0002-5139-9635
Morales-Sanfrutos, Julia https://orcid.org/0000-0002-0367-2932
Tate, Edward W. https://orcid.org/0000-0003-2213-5814
License Information

Text and Data Mining valid from 2021-10-27

Version of Record valid from 2021-10-27
More Information

Article History

Received: 13 November 2020

Accepted: 5 July 2021

First Online: 27 October 2021

Competing interests

: E.W.T. is a director and shareholder of Myricx Pharma Ltd. and an inventor on a patent application describing NMT inhibitors including IMP-1088 (Bell, A. S., Tate, E. W., Leatherbarrow, R. J., Hutton, J. A., Brannigan, J. A. Compounds and their use as inhibitors of <i>N</i>-myristoyl transferase. PCT In Appl. (2017) WO 2017001812).

Document is current

Any future updates will be listed below